Comprehensive Molecular Tumor Analysis
The CMTA is a new generation molecular profiling technology that integrates transcriptome (RNAseq) to whole exome and/or genome sequencing. This test significantly enhances the scope of precision oncology diagnostics. more…
For Clinicians
The benefits of comprehensive molecular tumor and micorenvironment profiling for treatment recommendations are increasingly recognized, opening up a novel dimension in personalized oncology. more…
For Patients
Overcoming the obstacles:
Every cancer is different. Personalized comprehensive diagnostics based on tumor sequencing helps to better understand the biology of individual tumors, which provides a support guiding treatment choice. more…
For the Pharmaceutical Industry
Digital Twins to help virtualise drug development:
ModCell™ is an innovative tool designed to model the tumor response to specific therapies or therapy combinations based on deep omics data.
A unique opportunity to virtualise and accelerate drug discovery and development. more…
